| Scientific Name |
Eliglustat
|
|---|---|
| Brand Name |
Cerdelga
|
| Risk |
Drug-drug interaction: Use with CYP2D6 and/or CYP3A inhibitors, strong CYP3A inducers, P-gp or CYP2D6 substrates, Use of eliglustat in patients who are CYP2D6 indeterminate metabolizers or non-genotyped patients, Off label use in Gaucher disease type 2 and 3.
|
| Educational Materials for Healthcare Professionals |
|
| Educational Materials for Patients |
|